CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Treatment options after sorafenib failure in patients with hepatocellular carcinoma
Imane El Dika, Ghassan K. Abou-Alfa
Clin Mol Hepatol. 2017;23(4):273-279.   Published online 2017 November 20    DOI: https://doi.org/10.3350/cmh.2017.0108

Excel Download

Treatment options after sorafenib failure in patients with hepatocellular carcinoma
Clinical and Molecular Hepatology. 2017;23(4):273-279   Crossref logo
Link1 Link2 Link3

Characteristics of 18 patients with hepatocellular carcinoma who obtained a complete response after treatment with sorafenib
Hepatology Research. 2014;44(13):1268-1276   Crossref logo
Link1 Link2

Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
Clinical and Molecular Hepatology. 2020;26(3):305-308   Crossref logo
Link1 Link2 Link3

Nivolumab vesus Regorafenib in patients with hepatocellular carcinoma after Sorafenib failure
. 2021;   Crossref logo
Link1 Link2

Sorafenib in the treatment of Hepatocellular carcinoma (HCC) patients with microvascular infiltration: a systematic review and meta-analysis
. 2020;   Crossref logo
Link1 Link2

Treatment Patterns and Health Resource Utilization in Patients With Hepatocellular Carcinoma After Failure of Sorafenib in Real-World Setting in Taiwan
Value in Health Regional Issues. 2022;30:76-82   Crossref logo
Link1 Link2

Sorafenib as second‐line treatment option after failure of lenvatinib in patients with unresectable hepatocellular carcinoma
JGH Open. 2020;4(6):1135-1139   Crossref logo
Link1 Link2 Link3 Link4

Sorafenib-Associated Heart Failure Complicated by Cardiogenic Shock after Treatment of Advanced Stage Hepatocellular Carcinoma: A Clinical Case Discussion
Case Reports in Cardiology. 2017;2017:1-9   Crossref logo
Link1 Link2 Link3

Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib Treatment
Oncology. 2010;79(1-2):85-92   Crossref logo
Link1 Link2

ALBI Grade Determines Post-Progression Survivals after Sorafenib Treatment Failure in Advanced Hepatocellular Carcinoma Patients: A Model for Second-Line Trial Selection
Journal of Hepatology. 2016;64(2):S699-S700   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.